Atlas Trials

The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters.

Clinical trial NCT03850314 · UNKNOWN

Trial details

NCT number
NCT03850314
Sponsor
Prof. Tony hayek MD
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Metabolic SyndromeDyslipidemiasDiabetes MellitusObesityAtherosclerosis
Start date
2019-03-01
Primary completion
2019-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.